A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
We conducted a genome-wide association analysis of 7 subfractions of low density lipoproteins (LDLs) and 3 subfractions of intermediate density lipoproteins (IDLs) measured by gradient gel electrophoresis, and their response to statin treatment, in 1868 individuals of European ancestry from the Pharmacogenomics and Risk of Cardiovascular Disease study. Our analyses identified four previously-implicated loci (SORT1, APOE, LPA, and CETP) as containing variants that are very strongly associated with lipoprotein subfractions (log 10 Bayes Factor > 15). Subsequent conditional analyses suggest that three of these (APOE, LPA and CETP) likely harbor multiple independently associated SNPs. Further, while different variants typically showed different characteristic patterns of association with combinations of subfractions, the two SNPs in CETP show strikingly similar patterns - both in our original data and in a replication cohort - consistent with a common underlying molecular mechanism. Notably, the CETP variants are very strongly associated with LDL subfractions, despite showing no association with total LDLs in our study, illustrating the potential value of the more detailed phenotypic measurements. In contrast with these strong subfraction associations, genetic association analysis of subfraction response to statins showed much weaker signals (none exceeding log 10 Bayes Factor of 6). However, two SNPs (in APOE and LPA) previously-reported to be associated with LDL statin response do show some modest evidence for association in our data, and the subfraction response profiles at the LPA SNP are consistent with the LPA association, with response likely being due primarily to resistance of Lp(a) particles to statin therapy. An additional important feature of our analysis is that, unlike most previous analyses of multiple related phenotypes, we analyzed the subfractions jointly, rather than one at a time. Comparisons of our multivariate analyses with standard univariate analyses demonstrate that multivariate analyses can substantially increase power to detect associations. Software implementing our multivariate analysis methods is available at http://stephenslab.uchicago.edu/software.html Author Summary Levels of plasma lipids and lipoproteins are related to risk of cardiovascular disease (CVD), and because of this, considerable attention has been devoted to genetic association analyses of lipid-related measures. In addition, motivated by the fact that statins are widely prescribed to lower plasma low density lipoprotein (LDL) cholesterol and CVD risk, and that response to statins has a genetic component, several studies have searched for genetic associations with response of lipid related phenotypes to statin treatment. Here, in 1868 individuals of European ancestry from the Pharmacogenomics and Risk of Cardiovascular Disease study, we have conducted genetic association analyses of 7 subfractions of LDLs and 3 subfractions of intermediate density lipoproteins (IDLs) measured by gradient gel electrophoresis, and their response to statin treatment. These phenotypic measurements offer higher resolution information on LDLs and IDLs than available previously. Therefore, our study provides a more detailed picture of association with the entire IDL/LDL subfraction profile than any prior genetic association studies of either lipid-related measures or their response to statin treatment. Moreover, unlike most previous analyses of multiple related measurements, we analyzed the subfractions jointly, rather than one at a time. Our results demonstrate that joint analyses of related measurements can considerably increase power to detect associations compared with conventional univariate analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationA haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Howie, B. N., Donnelly, P., & Marchini, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000529 · Cited by 3,928 · cited 4×
“2 Imputation quality reported from the software IMPUTE2 [10]; “+” for the typed SNP.”
MethodInfluentialRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citationBiological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487 · cited 9×
“All these genes have been previously identified as containing SNPs associated with LDL-C in a large (univariate) meta-analysis of over 100,000 individuals [1], and also identified as being associated with lipid subfractions measured by an NMR-based method, which distinguishes three subfractions of IDLs and LDLs [2].”
BackgroundMethodInfluentialSelf-citationLocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707 · cited 1×
“Regional plots of the four loci are created by using the tool LocusZoom [43] (with log10 BFav in y-axis).”
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Self-citationFrom noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140 · cited 1×
“This SNP is in high LD (r(2) = 1) with the SNP rs12740374 that has been identified as a causal variant contributing to change in plasma LDL-C [26].”
BackgroundSelf-citation
Cited by
Large-scale association analyses identify host factors influencing human gut microbiome composition
Kurilshikov, A., Medina-Gomez, C., Bacigalupe, R., Radjabzadeh, D., Wang, J., Demirkan, A., Le Roy, C. I., Raygoza Garay, J. A., Finnicum, C. T., Liu, X., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00763-1 · Cited by 1,786
Genetic analyses of diverse populations improves discovery for complex traits
Wojcik, G. L., Graff, M., Nishimura, K. K., Tao, R., Haessler, J., Gignoux, C. R., Highland, H. M., Patel, Y. M., Sorokin, E. P., Avery, C. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1310-4 · Cited by 1,033
From genome-wide associations to candidate causal variants by statistical fine-mapping
Schaid, D. J., Chen, W., & Larson, N. B. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0016-z · Cited by 885
Zhao, J. H., Stacey, D., Eriksson, N., Macdonald-Dunlop, E., Hedman, Å. K., Kalnapenkis, A., Enroth, S., Cozzetto, D., Digby-Bell, J., Marten, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01588-w · Cited by 747
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
Papadimitriou, N., Dimou, N., Tsilidis, K. K., Banbury, B., Martin, R. M., Lewis, S. J., Kazmi, N., Robinson, T. M., Albanes, D., Aleksandrova, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14389-8 · Cited by 652
Cannabis use and risk of schizophrenia: a Mendelian randomization study
Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith, D. J., Pell, J. P., Sattar, N., Paré, G., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.252 · Cited by 260
Causal associations between modifiable risk factors and the Alzheimer's phenome
Andrews, S. J., Fulton‐Howard, B., O'Reilly, P., Marcora, E., Goate, A. M., & collaborators of the Alzheimer's Disease Genetics Consortium (2021) · Annals of Neurology · doi:10.1002/ana.25918 · Cited by 156
“The proportion of variance in the phenotype explained by each instrument and F-statistic were calculated, as previously described.(41,42)”
MethodA major locus controls local adaptation and adaptive life history variation in a perennial plant
Wang, J., Ding, J., Tan, B., Robinson, K. M., Michelson, I. H., Johansson, A., Nystedt, B., Scofield, D. G., Nilsson, O., Jansson, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1444-y · Cited by 145
Statistical methods to detect pleiotropy in human complex traits
Hackinger, S., & Zeggini, E. (2017) · Open Biology · doi:10.1098/rsob.170125 · Cited by 143
Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study
Zeng, P., & Zhou, X. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy384 · Cited by 130
“the index SNP using summary statistics following the method presented in (70).”
MethodAssociation between alcohol consumption and Alzheimer's disease: A Mendelian randomization study
Andrews, S. J., Goate, A., & Anstey, K. J. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.09.086 · Cited by 82
Genome-wide study on 72,298 individuals in Korean biobank data for 76 traits
Nam, K., Kim, J., & Lee, S. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100189 · Cited by 77
Young, W. J., Lahrouchi, N., Isaacs, A., Duong, T., Foco, L., Ahmed, F., Brody, J. A., Salman, R., Noordam, R., Benjamins, J.-W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32821-z · Cited by 49
Purification of multiplex oligonucleotide libraries by synthesis and selection
Choi, H., Choi, Y., Choi, J., Lee, A. C., Yeom, H., Hyun, J., Ryu, T., & Kwon, S. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-00988-3 · Cited by 32
Lipids and amyotrophic lateral sclerosis: A two‐sample Mendelian randomization study
Xia, K., Klose, V., Högel, J., Huang, T., Zhang, L., Dorst, J., Fan, D., & Ludolph, A. C. (2023) · European Journal of Neurology · doi:10.1111/ene.15810 · Cited by 27
“The phenotypic variance explanation (R2, R2 = 2 × beta2 × [1− EAF] × EAF/SD2, EAF = effect allele frequency, beta = effect of each SNP on exposures) [33] and F- statistics (F = R2 × [N−2]/[1−R2]) [34] of each IV were calculated to assess their strength.”
MethodA selection pressure landscape for 870 human polygenic traits
Song, W., Shi, Y., Wang, W., Pan, W., Qian, W., Yu, S., Zhao, M., & Lin, G. N. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01231-4 · Cited by 25
“However, we used a different estimation approach proposed by Shim et al.(59), which required less input variables: %vvttNNccttiiccNN = 2 ∗ DDDDDD ∗ (1 − DDDDDD) ∗ ββ2 2 ∗ DDDDDD ∗ (1 − DDDDDD) ∗ ββ2 + 2 ∗ DDDDDD ∗ (1 − DDDDDD) ∗ NN ∗ ccNN(ββ)2 Where β was the effect size, N was the sample size of GWAS, and se(β) was t…”
Metadata
- Authors
- Shim, H., Chasman, D. I., Smith, J. D., Mora, S., Ridker, P. M., Nickerson, D. A., Krauss, R. M., & Stephens, M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-21
- Volume
- 10
- Issue
- 4
- Pages
- e0120758
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2144596601
- Cited by
- 558
- References
- 42
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.